论文信息 - Investigation on the optimal implantation site and setting of Reveal LINQ® avoiding interference with performance of transthoracic echocardiography

Investigation on the optimal implantation site and setting of Reveal LINQ® avoiding interference with performance of transthoracic echocardiography

The optimal implantation site of a new implantable cardiac monitor (ICM) named Reveal LINQ® may be limited based on a sufficient amplitude of R wave potential (AEP) acquisition because it is the same anatomic area used for transthoracic echocardiography (TTE).

[1] A. Brandes,et al. Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial , 2017, American heart journal.

[2] B. Bijnens,et al. Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy. , 2016, The American journal of cardiology.

[3] A. Natale,et al. Initial real world experience with a novel insertable (Reveal LinQ(@Medtronic)) compared to the conventional (Reveal XT(@Medtronic)) implantable loop recorder at a tertiary care center - Points to ponder! , 2015, International journal of cardiology.

[4] N. Goldschlager,et al. Implantable cardiac arrhythmia devices—Part II: Implantable cardioverter defibrillators and implantable loop recorders , 2006, Clinical cardiology.

[5] R Yee,et al. Randomized Assessment of Syncope Trial: Conventional Diagnostic Testing Versus a Prolonged Monitoring Strategy , 2001, Circulation.

[6] P. Hong,et al. Implantable diagnostic monitors in the early assessment of syncope and collapse. , 2013, Progress in cardiovascular diseases.